Fetal and neonatal involvement in maternal rheumatologic disease

References

• Gcelu A. Rheumatic diseases and pregnancy. S Afr Med J. 2014;104:643.
   PubMed Web of Science ®Google Scholar
• Wiik AS, Gordon TP, Kavanaugh AF, et al. Cutting edge diagnostics in rheumatology: the role of patients, clinicians, and laboratory scientists in optimizing the use of autoimmune serology. Arthritis Rheumat. 2004;51:291–298.
   PubMed Web of Science ®Google Scholar
• Østensen M, Khamashta M, Lockshin M, et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther. 2006;8:209.
   PubMed Web of Science ®Google Scholar
• Bundhun PK, Soogund MZ, Huang F. Impact of systemic lupus erythematosus on maternal and fetal outcomes following pregnancy: a meta-analysis of studies published between years 2001–2016. J Autoimmun. 2017;79:17–27.
   PubMed Web of Science ®Google Scholar
• Song YJ, Liu DZ, Liu JT, et al. Predictors of maternal and fetal outcomes in systemic lupus erythematosus: a retrospective study of 94 cases. Zhonghua Nei Ke Za Zhi. 2008;47:1008–1011.
   PubMedGoogle Scholar
• Moroni G, Doria A, Giglio E, et al. Fetal outcome and recommendations of pregnancies in lupus nephritis in the 21st century. A prospective multicenter study. J Autoimmun. 2016;74:6–12.
   PubMed Web of Science ®Google Scholar
• Lazzaroni MG, Dall'Ara F, Fredi M, et al. A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus. J Autoimmun. 2016;74:106–117.
   PubMed Web of Science ®Google Scholar
• Mecacci F, Pieralli A, Bianchi B, et al. The impact of autoimmune disorders and adverse pregnancy outcome. Semin Perinatol. 2007;31:223–226.
   PubMed Web of Science ®Google Scholar
• Brito-Zerón P, Izmirly PM, Ramos-Casals M, et al. Autoimmune congenital heart block: complex and usual situations. Lupus. 2016;25:116–128.
   PubMed Web of Science ®Google Scholar
• Mekinian A, Lachassinne E, Nicaise-Roland P, et al. European registry of babies born to mothers with antiphospholipid syndrome. Ann Rheum Dis. 2013;72:217–222.
   PubMed Web of Science ®Google Scholar
• Götestam Skorpen C, Hoeltzenbein M, Tincani A, et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis. 2016;75:795–810.
   PubMed Web of Science ®Google Scholar
• Gupta S, Gupta N. Sjögren syndrome and pregnancy: a literature review. Perm J. 2017;21:16–47. doi: 10.7812/TPP/16-047
   PubMedGoogle Scholar
• Hussein SZ, Jacobsson LT, Lindquist PG, et al. Pregnancy and fetal outcome in women with primary Sjogren’s syndrome compared with women in the general population: a nested case-control study. Rheumatology (Oxford). 2011;50:1612–1617.
   PubMed Web of Science ®Google Scholar
• Priori R, Gattamelata A, Modesti M, et al. Outcome of pregnancy in Italian patients with primary Sjögren syndrome. J Rheumatol. 2013;40:1143–1147.
   PubMed Web of Science ®Google Scholar
• Baruteau AE, Pass RH, Thambo JB, et al. Congenital and childhood atrioventricular blocks: pathophysiology and contemporary management. Eur J Pediatr. 2016;175:1235–1248.
   PubMed Web of Science ®Google Scholar
• Cuneo BF, Lee M, Roberson D, et al. A management strategy for fetal immune-mediated atrioventricular block. J Matern Fetal Neonatal Med. 2010;23:1400–1405.
   PubMed Web of Science ®Google Scholar
• Lin HC, Chen SF, Lin HC, et al. Increased risk of adverse pregnancy outcomes in women with rheumatoid arthritis: a nationwide population-based study. Ann Rheum Dis. 2010;69:715–717.
   PubMed Web of Science ®Google Scholar
• Bharti B, Lee SJ, Lindsay SP, et al. Disease severity and pregnancy outcomes in women with rheumatoid arthritis: results from the organization of Teratology Information Specialists Autoimmune Diseases in Pregnancy project. J Rheumatol. 2015;42:1376–1382.
   PubMed Web of Science ®Google Scholar
• Krause ML, Amin S, Makol A. Use of DMARDs and biologics during pregnancy and lactation in rheumatoid arthritis: what the rheumatologist needs to know. Ther Adv Musculoskelet Dis. 2014;6:169–184.
   PubMedGoogle Scholar
• Williams M, Chakravarty EF. Rheumatoid arthritis and pregnancy: impediments to optimal management of both biologic use before, during and after pregnancy. Curr Opin Rheumatol. 2014;26:341–346.
   PubMed Web of Science ®Google Scholar
• Missumi LS, Souza FH, Andrade JQ, et al. Pregnancy outcome in dermatomyositis and polymyositis patients. Rev Bras Reumatol. 2015;55:95–102.
   PubMed Web of Science ®Google Scholar
• Silva CA, Sultan SM, Isenberg DA. Pregnancy outcome in adult-onset idiopathic inflammatory myopathy. Rheumatology (Oxford). 2003;42:1168–1172.
   PubMed Web of Science ®Google Scholar
• Williams L, Chang PY, Park E, et al. Successful treatment of dermatomyositis during pregnancy with intravenous immunoglobulin monotherapy. Obstet Gynecol. 2007;109:561–563.
   PubMed Web of Science ®Google Scholar
• Rios Fernández R, Callejas Rubio JL, Sánchez Cano D, et al. Rituximab in the treatment of dermatomyositis and other inflammatory myopathies. A report of 4 cases and review of the literature. Clin Exp Rheumatol. 2009;27:1009–1016.
   PubMed Web of Science ®Google Scholar
• Muscle Study Group. A randomized, pilot trial of etanercept in dermatomyositis. Ann Neurol. 2011;70:427–436.
   PubMed Web of Science ®Google Scholar
• Chung L, Flyckt RL, Colón I, et al. Outcome of pregnancies complicated by systemic sclerosis and mixed connective tissue disease. Lupus. 2006;15:595–599.
   PubMed Web of Science ®Google Scholar
• Taraborelli M, Ramoni V, Brucato A, et al. Brief report: successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter study. Arthritis Rheum. 2012;64:1970–1977.
   PubMed Web of Science ®Google Scholar
• Steen VD. Pregnancy in scleroderma. Rheum Dis Clin N Am. 2007;33:345–358.
   PubMed Web of Science ®Google Scholar
• Lidar M, Langevitz P. Pregnancy issues in scleroderma. Autoimmun Rev. 2012;11:A515–A519.
   PubMed Web of Science ®Google Scholar
• Soh MC, Nelson-Piercy C. High-risk pregnancy and the rheumatologist. Rheumatology (Oxford). 2015;54:572–587.
   PubMed Web of Science ®Google Scholar
• Cappelli S, Bellando-Randone S, Guiducci S, et al. Is immunosuppressive therapy the anchor treatment to achieve remission in systemic sclerosis? Rheumatology (Oxford). 2014;53:975–987.
   PubMed Web of Science ®Google Scholar
• Clowse ME. Managing contraception and pregnancy in the rheumatologic diseases. Best Pract Res Clin Rheumatol. 2010;24:373–385.
   PubMed Web of Science ®Google Scholar
• Tincani A, Nuzzo M, Lojacono A, et al. Contraception in adolescents with systemic lupus erythematosus. Lupus. 2007;16:600–605.
   PubMed Web of Science ®Google Scholar
• Sammaritano LR. Therapy insight: guidelines for selection of contraception in women with rheumatic diseases. Nat Clin Pract Rheumatol. 2007;3:273–281.
   PubMedGoogle Scholar